首页 > 最新文献

Acta anaesthesiologica Belgica最新文献

英文 中文
Unusual cause of obstructive shock following esophagectomy: a case report 食管切除术后梗阻性休克的不寻常原因1例
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.56126/72.4.5
S. Boccar, R. Rubay, M. Richard, P. Reper, G. Horlait, A. Goussen, V. De Moor, P. Bulpa
Obstructive shock usually has an intrathoracic origin, such as pneumothorax, pericardial tamponade or pulmonary embolism. We report a case of hemo- dynamic shock in a 74-year-old patient four days after esophagectomy, just after the start of mechanical ventilation for bilateral pneumonia. The sudden onset of severe abdominal distension and the presence of air in the intra-abdominal drain suggested tension pneumoperitoneum, confirmed by radiography. No pneumothorax was associated. Urgent decompression was required to improve hemodynamics. Perforation of the gastrointestinal tract was ruled out. The cause was a bronchopleural fistula opened by mechanical ventilation. Rarely, cardiorespiratory failure may occur after tension pneumoperitoneum by reducing lung volume and cardiac preload, similar to obstructive shock from the usual intrathoracic causes or acting as an abdominal compartment syndrome (ACS). Its recognition and abdominal decompression are key steps in the patient’s recovery. Tension pneumoperitoneum related to mechanical ventilation and airway injury without associated pneumothorax is exceptional and, to our knowledge, has never been reported as a postoperative complication of esophagectomy.
梗阻性休克通常起源于胸内,如气胸、心包填塞或肺栓塞。我们报告一例74岁的患者,在双侧肺炎开始机械通气后,食道切除术后4天发生血液动力学休克。突然发作的严重腹胀和腹内引流管中存在空气提示张力性气腹,经x线摄影证实。无气胸相关。需要紧急减压以改善血流动力学。排除了胃肠道穿孔。原因是机械通气导致支气管胸膜瘘。紧张性气腹术后,肺容量和心脏预负荷减少,可能导致心肺衰竭,类似于通常胸腔内原因引起的阻塞性休克,或表现为腹腔隔室综合征(ACS)。其识别和腹部减压是患者康复的关键步骤。张力性气腹与机械通气和气道损伤相关,无气胸是例外,据我们所知,从未报道过作为食管切除术术后并发症。
{"title":"Unusual cause of obstructive shock following esophagectomy: a case report","authors":"S. Boccar, R. Rubay, M. Richard, P. Reper, G. Horlait, A. Goussen, V. De Moor, P. Bulpa","doi":"10.56126/72.4.5","DOIUrl":"https://doi.org/10.56126/72.4.5","url":null,"abstract":"Obstructive shock usually has an intrathoracic origin, such as pneumothorax, pericardial tamponade or pulmonary embolism. We report a case of hemo- dynamic shock in a 74-year-old patient four days after esophagectomy, just after the start of mechanical ventilation for bilateral pneumonia. The sudden onset of severe abdominal distension and the presence of air in the intra-abdominal drain suggested tension pneumoperitoneum, confirmed by radiography. No pneumothorax was associated. Urgent decompression was required to improve hemodynamics. Perforation of the gastrointestinal tract was ruled out. The cause was a bronchopleural fistula opened by mechanical ventilation. Rarely, cardiorespiratory failure may occur after tension pneumoperitoneum by reducing lung volume and cardiac preload, similar to obstructive shock from the usual intrathoracic causes or acting as an abdominal compartment syndrome (ACS). Its recognition and abdominal decompression are key steps in the patient’s recovery. Tension pneumoperitoneum related to mechanical ventilation and airway injury without associated pneumothorax is exceptional and, to our knowledge, has never been reported as a postoperative complication of esophagectomy.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44348470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative pain after cesarean section: an audit of practice after implementation of the PROSPECT recommendations 剖宫产术后疼痛:实施PROSPECT建议后的实践审计
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.56126/72.3.1
N. Gharae, E. Roofthooft, N. Fileticci, S. Devroe, P. Vanhove, S. Rex, M. Van de Velde
Cesarean section (CS) is the most frequently performed surgical intervention worldwide. Post- cesarean pain is often underestimated and undertreated and can impair rapid maternal recovery, mother and child bonding and breastfeeding. Recently, PROSPECT recommendations on postoperative pain for CS were published and they include systematic paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), intravenous dexamethasone, neuraxial morphine/dia- morphine or an abdominal wall block or wound infiltration, abdominal wall binders, non-closure of the peritoneum and a Joel-Cohen incision. Opioids are administered as rescue. In UZ Leuven, these PROSPECT recommendations were implemented at the end of 2020. To evaluate the efficacy of these PROSPECT recommendations, a prospective audit was performed from January 1 st , 2021 till April 30 th , 2021. All patients with a CS were prospectively followed for correct implementation of the pain protocol and for pain scores in rest and at mobilization. Rescue opioid consumption as well as patient satisfaction were recorded. 185 consecutive patients that had undergone a CS were included in the audit. In 55 patients the pain protocol was not followed mostly due to no or reduced administration of NSAIDs. Patient satisfaction was high, especially in patients in which the protocol was followed. Pain scores at rest and at mobilization were low and the percentage of patients having pain scores above 30 mm VAS remained low. Rescue opioid consumption was low. We conclude that the implementation of the PROSPECT based pain protocol after CS was effective in controlling pain, reducing opioid consumption and resulted in high patient satisfaction especially if the protocol was correctly followed. Omission of NSAIDs is occurring relatively frequent, but mostly because of valid medical reasons to omit NSAIDs.
剖宫产(CS)是世界上最常见的外科干预措施。剖宫产后的疼痛往往被低估和治疗不足,会影响产妇的快速康复、母子关系和母乳喂养。最近,发表了关于CS术后疼痛的PROSPECT建议,其中包括系统性对乙酰氨基酚和非甾体抗炎药(NSAIDs)、静脉注射地塞米松、轴索吗啡/二吗啡或腹壁阻滞或伤口浸润、腹壁粘合剂、腹膜不闭合和Joel Cohen切口。阿片类药物是作为抢救用药的。在鲁汶大学,这些PROSPECT建议于2020年底实施。为了评估这些前瞻性建议的有效性,从2021年1月1日至2021年4月30日进行了前瞻性审计。对所有CS患者进行前瞻性随访,以正确执行疼痛方案,并在休息和活动时进行疼痛评分。记录了救援阿片类药物的消耗量以及患者的满意度。185名连续接受CS的患者被纳入审计。在55名患者中,疼痛方案没有得到遵守,主要是由于没有服用或减少服用非甾体抗炎药。患者满意度很高,尤其是在遵守方案的患者中。休息和活动时的疼痛评分较低,疼痛评分超过30mm VAS的患者比例仍然较低。救援阿片类药物的消费量很低。我们得出的结论是,CS后实施基于PROSPECT的疼痛方案在控制疼痛、减少阿片类药物消耗方面是有效的,并导致患者的高满意度,尤其是在正确遵循该方案的情况下。非甾体抗炎药的省略相对频繁,但主要是因为省略非甾体消炎药的正当医学原因。
{"title":"Postoperative pain after cesarean section: an audit of practice after implementation of the PROSPECT recommendations","authors":"N. Gharae, E. Roofthooft, N. Fileticci, S. Devroe, P. Vanhove, S. Rex, M. Van de Velde","doi":"10.56126/72.3.1","DOIUrl":"https://doi.org/10.56126/72.3.1","url":null,"abstract":"Cesarean section (CS) is the most frequently performed surgical intervention worldwide. Post- cesarean pain is often underestimated and undertreated and can impair rapid maternal recovery, mother and child bonding and breastfeeding. Recently, PROSPECT recommendations on postoperative pain for CS were published and they include systematic paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), intravenous dexamethasone, neuraxial morphine/dia- morphine or an abdominal wall block or wound infiltration, abdominal wall binders, non-closure of the peritoneum and a Joel-Cohen incision. Opioids are administered as rescue. In UZ Leuven, these PROSPECT recommendations were implemented at the end of 2020. To evaluate the efficacy of these PROSPECT recommendations, a prospective audit was performed from January 1 st , 2021 till April 30 th , 2021. All patients with a CS were prospectively followed for correct implementation of the pain protocol and for pain scores in rest and at mobilization. Rescue opioid consumption as well as patient satisfaction were recorded. 185 consecutive patients that had undergone a CS were included in the audit. In 55 patients the pain protocol was not followed mostly due to no or reduced administration of NSAIDs. Patient satisfaction was high, especially in patients in which the protocol was followed. Pain scores at rest and at mobilization were low and the percentage of patients having pain scores above 30 mm VAS remained low. Rescue opioid consumption was low. We conclude that the implementation of the PROSPECT based pain protocol after CS was effective in controlling pain, reducing opioid consumption and resulted in high patient satisfaction especially if the protocol was correctly followed. Omission of NSAIDs is occurring relatively frequent, but mostly because of valid medical reasons to omit NSAIDs.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42860420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The use of methylprednisolone in patients with Coronavirus disease 2019 (COVID-19) requiring intensive care hospitalization: a longitudinal observational study 甲基强的松龙在需要重症监护住院的2019冠状病毒病(COVID-19)患者中的应用:一项纵向观察研究
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.56126/72.3.4
L. Doucet, S. Hoflack, L. Van Slambrouck, P. Lormans
The use of methylprednisolone in patients with Coronavirus disease 2019 (COVID-19) requiring intensive care hospitalization: a longitudinal observational study.Background : For a long time, the use of corticosteroids in critically ill patients with coronavirus disease 2019 (COVID-19) has been a controversial treatment. How- ever, given the conflicting evidence on this topic, we studied the effects of methylprednisolone on critically ill patients and - share here our experience on laboratory findings and the Pa02/FiO2 ratio (ratio of partial oxygen concentration on arterial blood gas sample to fraction of inspired oxygen).Methods : In a population of 68 patients hospitalized in the intensive care unit due because of COVID-19 infection, 28 patients with severe respiratory failure received methylprednisolone on a fixed 12-day regimen (125 mg IV for 2 days, followed by 2x0.5 mg/kg IV twice daily for 5 days, and then a decreasing regimen for 4 days until discontinuation). After day 5 and day 10, we analyzed the levels of CRP (C-reactive protein), lymphocytosis, D-dimer, LDH (lactate dehydrogenase) and PaO 2 /FiO 2 ratio of our patients.Results : We observed a significant decrease in median CRP levels between day 0 (start of methylprednisolone treatment) and day 5 (p=0.001), and between day 0 and day 10 (p=0.005). No decrease was seen between day 5 and 10 (p=0.352). The same increase in PaO 2 /FiO 2 was recorded between day 0 and day 5 (p=0.009), and between 0 and day 10 (p=0.019). For D-dimer, only a significant difference was found between day 0 and day 10 (p=0.018). No significant difference could be observed for lymphocytosis and LDH levels between the beginning of the treatment and day 5 or day 10.Conclusion : There is a strong and sustained significant decrease in CRP levels and a tilt in the PaO2/FiO2 ratio after starting methylprednisolone. A slower, but also significant decrease was found for D-dimer. Further research and control group analyses are needed to confirm that this effect is due to corticostreoid treatment. However, this indicates that methylprednisolone may play a very important role in the treatment of the severely ill COVID-19 patients requiring ICU admission.
甲基强的松龙在需要重症监护住院治疗的2019冠状病毒病(新冠肺炎)患者中的使用:一项纵向观察研究。背景:长期以来,在2019冠状病毒病(新冠肺炎)危重患者中使用皮质类固醇一直是一种有争议的治疗方法。然而,鉴于这一主题的相互矛盾的证据,我们研究了甲基强的松龙对危重患者的影响,并在这里分享了我们在实验室发现和Pa02/FiO2比率(动脉血气样本的部分氧浓度与吸入氧分数的比率)方面的经验。方法:在68名因新冠肺炎感染而在重症监护室住院的患者中,28名严重呼吸衰竭患者接受了为期12天的固定方案甲基强的松龙治疗(125 mg IV,为期2天,随后2次0.5 mg/kg IV,为期5天,每天两次,然后递减方案,为期4天,直至停药)。在第5天和第10天之后,我们分析了我们的患者的CRP(C反应蛋白)、淋巴细胞增多症、D-二聚体、LDH(乳酸脱氢酶)和PaO2/FiO2比率的水平。结果:我们观察到,在第0天(开始甲基强的松龙治疗)到第5天(p=0.001),以及第0天到第10天(p=0.005),中位CRP水平显著下降。在第5天到第十天之间没有下降(p=0.052)。在第0天至第5天之间(p=0.009)和第0天至第10天之间(p=0.019),在第0天和第10天之间仅发现显著差异(p=0.018)。在治疗开始和第5天或第10天期间,淋巴细胞增多症和LDH水平没有观察到显著差异。结论:在开始甲基强的松龙后,CRP水平显著且持续地显著下降,PaO2/FiO2比率倾斜。D-二聚体的下降速度较慢,但也很显著。需要进一步的研究和对照组分析来证实这种影响是由皮质类固醇治疗引起的。然而,这表明甲基强的松龙可能在治疗需要入住ICU的重症新冠肺炎患者中发挥非常重要的作用。
{"title":"The use of methylprednisolone in patients with Coronavirus disease 2019 (COVID-19) requiring intensive care hospitalization: a longitudinal observational study","authors":"L. Doucet, S. Hoflack, L. Van Slambrouck, P. Lormans","doi":"10.56126/72.3.4","DOIUrl":"https://doi.org/10.56126/72.3.4","url":null,"abstract":"The use of methylprednisolone in patients with Coronavirus disease 2019 (COVID-19) requiring intensive care hospitalization: a longitudinal observational study.\u0000\u0000Background : For a long time, the use of corticosteroids in critically ill patients with coronavirus disease 2019 (COVID-19) has been a controversial treatment. How- ever, given the conflicting evidence on this topic, we studied the effects of methylprednisolone on critically ill patients and - share here our experience on laboratory findings and the Pa02/FiO2 ratio (ratio of partial oxygen concentration on arterial blood gas sample to fraction of inspired oxygen).\u0000\u0000Methods : In a population of 68 patients hospitalized in the intensive care unit due because of COVID-19 infection, 28 patients with severe respiratory failure received methylprednisolone on a fixed 12-day regimen (125 mg IV for 2 days, followed by 2x0.5 mg/kg IV twice daily for 5 days, and then a decreasing regimen for 4 days until discontinuation). After day 5 and day 10, we analyzed the levels of CRP (C-reactive protein), lymphocytosis, D-dimer, LDH (lactate dehydrogenase) and PaO 2 /FiO 2 ratio of our patients.\u0000\u0000Results : We observed a significant decrease in median CRP levels between day 0 (start of methylprednisolone treatment) and day 5 (p=0.001), and between day 0 and day 10 (p=0.005). No decrease was seen between day 5 and 10 (p=0.352). The same increase in PaO 2 /FiO 2 was recorded between day 0 and day 5 (p=0.009), and between 0 and day 10 (p=0.019). For D-dimer, only a significant difference was found between day 0 and day 10 (p=0.018). No significant difference could be observed for lymphocytosis and LDH levels between the beginning of the treatment and day 5 or day 10.\u0000\u0000Conclusion : There is a strong and sustained significant decrease in CRP levels and a tilt in the PaO2/FiO2 ratio after starting methylprednisolone. A slower, but also significant decrease was found for D-dimer. Further research and control group analyses are needed to confirm that this effect is due to corticostreoid treatment. However, this indicates that methylprednisolone may play a very important role in the treatment of the severely ill COVID-19 patients requiring ICU admission.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41317277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Internal jugular vein valves complicating central venous catheter placement: a case report 颈内静脉瓣膜合并中心静脉导管置入术1例
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.56126/72.3.6
S. Pissens, M. Peetermans, A. Wilmer
Placement of central venous catheters in the internal jugular vein is a frequently performed procedure. We present the case of a patient with venous valves causing an unexpected anatomic hindrance in the placement of a central venous catheter in the internal jugular vein. Venous valves are common in the internal jugular vein and can hinder cannulation. Ultrasound can be of use in the proper placement of a central venous line in a patient where cannulation is complicated by venous valves.
在颈内静脉中放置中心静脉导管是一种经常进行的手术。我们介绍了一例患者的静脉瓣膜在颈内静脉放置中心静脉导管时造成意外的解剖障碍。静脉瓣膜常见于颈内静脉,可阻碍插管。在静脉瓣膜使插管复杂的患者中,超声可用于正确放置中心静脉线。
{"title":"Internal jugular vein valves complicating central venous catheter placement: a case report","authors":"S. Pissens, M. Peetermans, A. Wilmer","doi":"10.56126/72.3.6","DOIUrl":"https://doi.org/10.56126/72.3.6","url":null,"abstract":"Placement of central venous catheters in the internal jugular vein is a frequently performed procedure. We present the case of a patient with venous valves causing an unexpected anatomic hindrance in the placement of a central venous catheter in the internal jugular vein. Venous valves are common in the internal jugular vein and can hinder cannulation. Ultrasound can be of use in the proper placement of a central venous line in a patient where cannulation is complicated by venous valves.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46528687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of anesthesia for surgery in prone position for a patient with hereditary neuropathy with liability to pressure palsies. A case report and narrative literature review 易患压力性麻痹的遗传性神经病变患者俯卧位手术的麻醉管理。个案报告与叙述性文献综述
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.56126/72.3.7
C. Moerman, T. Van Havenbergh, P. Van Houwe, S. Casaer
The reported case describes a patient with hereditary neuropathy with liability to pressure palsies (HNPP) requiring a neurosurgical laminotomy procedure for an arachnoid cyst with medullary compression. HNPP is a rare pathology requiring meticulous anesthetic and surgical management. We give a detailed overview of the planning, simulation, and performance of the anesthesia procedure in order to minimize all potential risk factors for perioperative nerve injury. During the preparation of this case, where the positioning was extremely challenging, we reviewed the available literature for guidance. A few papers report the use of neuraxial anesthesia in patients previously diagnosed with HNPP. No reports could be found on the management of general anesthesia and positioning for major surgery in those patients.
报告的病例描述了一个遗传性神经病变与压力性麻痹(HNPP)的易感性,需要神经外科椎板切开术治疗蛛网膜囊肿与髓质压迫。HNPP是一种罕见的病理,需要细致的麻醉和手术治疗。为了尽量减少围手术期神经损伤的所有潜在危险因素,我们将详细概述麻醉过程的计划、模拟和执行。在本案例的准备过程中,定位极具挑战性,我们查阅了现有文献以寻求指导。一些论文报道了在先前诊断为HNPP的患者中使用神经轴麻醉。在这些患者的大手术中,没有关于全身麻醉和体位管理的报道。
{"title":"Management of anesthesia for surgery in prone position for a patient with hereditary neuropathy with liability to pressure palsies. A case report and narrative literature review","authors":"C. Moerman, T. Van Havenbergh, P. Van Houwe, S. Casaer","doi":"10.56126/72.3.7","DOIUrl":"https://doi.org/10.56126/72.3.7","url":null,"abstract":"The reported case describes a patient with hereditary neuropathy with liability to pressure palsies (HNPP) requiring a neurosurgical laminotomy procedure for an arachnoid cyst with medullary compression. HNPP is a rare pathology requiring meticulous anesthetic and surgical management. We give a detailed overview of the planning, simulation, and performance of the anesthesia procedure in order to minimize all potential risk factors for perioperative nerve injury. During the preparation of this case, where the positioning was extremely challenging, we reviewed the available literature for guidance. A few papers report the use of neuraxial anesthesia in patients previously diagnosed with HNPP. No reports could be found on the management of general anesthesia and positioning for major surgery in those patients.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43776201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A comparative study of transdiscal versus transaortic celiac plexus neurolytic block for upper gastrointestinal cancer patients. A prospective, randomized control study 上消化道癌症患者经椎间盘与经皮质腹腔丛神经阻滞的比较研究。一项前瞻性随机对照研究
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.56126/72.3.3
A. Rath, Reena, A. Paswan, M. Tewari
Aim: To compare transdiscal and transaortic techniques of neurolytic celiac plexus block for upper gastrointestinal cancer patients.Methods: In this prospective randomized study 60 patients with upper gastrointestinal malignancies were included and randomly divided into two groups, group TD and group TA, receiving neurolytic celiac plexus blocks via transdiscal and transaortic techniques, respectively. The primary outcome was quality of life (QoL) as assessed by WHOQOL BREF questionnaire and secondary outcomes were pain relief using visual analogue scale (VAS), and occurrence of complications like hypotension, loose motion, bleeding and discitis.Result: QoL and VAS score were significantly improved in both groups post procedure. Transdiscal approach is more effective in improving VAS score than transaortic approach (1 vs 3) after 1 week and the relief of pain was better in TD group (3 vs 6) at the end of 2 months. Transdiscal approach was found to be more effective in improving QoL (227.00±28.85 vs 191.17±35.78) as compared to transaortic approach. However, post-procedural QoL improved in both groups when compared to pre-procedural QoL (p<0.05). Hypotension, diarrhea and bleeding from aorta were higher in TA group; however, no serious complications were seen in any of the groups.Conclusion: Transdiscal technique is better in terms of adequate pain relief and improving QoL as compared to transaortic technique of NCPB in patients of upper GI malignancies and is associated with lesser incidences of complications.
目的:比较上消化道癌症患者腹腔神经丛阻滞的经椎间盘和经皮质技术。方法:在这项前瞻性随机研究中,60名上消化道恶性肿瘤患者被纳入并随机分为两组,TD组和TA组,分别通过经椎间和经皮质技术接受腹腔神经丛阻滞。主要结果是通过WHOQOL BREF问卷评估的生活质量(QoL),次要结果是使用视觉模拟量表(VAS)缓解疼痛,以及低血压、松动、出血和椎间盘炎等并发症的发生。结果:两组患者术后生活质量和VAS评分均有明显改善。1周后,经椎间盘入路在改善VAS评分方面比经皮质入路(1比3)更有效,并且在2个月结束时,TD组的疼痛缓解效果更好(3比6)。与经皮质入路相比,经椎间盘入路在改善生活质量方面更有效(227.00±28.85 vs 191.17±35.78)。但与术前相比,两组术后生活质量均有改善(p<0.05)。TA组低血压、腹泻和主动脉出血率较高;然而,在任何一组中都没有发现严重的并发症。结论:在上消化道恶性肿瘤患者中,与经皮质NCPB技术相比,经椎间盘技术在充分缓解疼痛和改善生活质量方面更好,并且并发症发生率更低。
{"title":"A comparative study of transdiscal versus transaortic celiac plexus neurolytic block for upper gastrointestinal cancer patients. A prospective, randomized control study","authors":"A. Rath, Reena, A. Paswan, M. Tewari","doi":"10.56126/72.3.3","DOIUrl":"https://doi.org/10.56126/72.3.3","url":null,"abstract":"Aim: To compare transdiscal and transaortic techniques of neurolytic celiac plexus block for upper gastrointestinal cancer patients.\u0000\u0000Methods: In this prospective randomized study 60 patients with upper gastrointestinal malignancies were included and randomly divided into two groups, group TD and group TA, receiving neurolytic celiac plexus blocks via transdiscal and transaortic techniques, respectively. The primary outcome was quality of life (QoL) as assessed by WHOQOL BREF questionnaire and secondary outcomes were pain relief using visual analogue scale (VAS), and occurrence of complications like hypotension, loose motion, bleeding and discitis.\u0000\u0000Result: QoL and VAS score were significantly improved in both groups post procedure. Transdiscal approach is more effective in improving VAS score than transaortic approach (1 vs 3) after 1 week and the relief of pain was better in TD group (3 vs 6) at the end of 2 months. Transdiscal approach was found to be more effective in improving QoL (227.00±28.85 vs 191.17±35.78) as compared to transaortic approach. However, post-procedural QoL improved in both groups when compared to pre-procedural QoL (p<0.05). Hypotension, diarrhea and bleeding from aorta were higher in TA group; however, no serious complications were seen in any of the groups.\u0000\u0000Conclusion: Transdiscal technique is better in terms of adequate pain relief and improving QoL as compared to transaortic technique of NCPB in patients of upper GI malignancies and is associated with lesser incidences of complications.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47361240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between mephentermine and ondansetron for the prevention of post spinal hypotension: a prospective randomized trial 甲芬特明和昂丹司琼预防脊髓后低血压的比较:一项前瞻性随机试验
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.56126/72.3.5
K. Shah, P. Dubey, A. Bharti, S. Singh
Background and Aims: Spinal anesthesia is a technique often associated with side effects like hypotension and bradycardia. Recent studies have shown that the use of ondansetron leads to a decreased incidence of hypotension induced by spinal anesthesia. This prospective, randomized, controlled, double-blind study was done to compare the efficacy of the prophylactic use of intravenous (IV) ondansetron and mephentermine on post-spinal hypotension.Methods: A total of 130 patients were randomly allocated to one of two groups: Group O received 4 mg IV ondansetron and Group M received 6 mg of IV mephentermine. All patients received spinal anesthesia using 3 mL of 0.5% hyperbaric bupivacaine. Assessment of blood pressure and heart rate (HR) was done for 30 minutes after spinal anesthesia was performed. Quantitative data were analyzed using ANOVA tests and qualitative data were analyzed using the Chi-square tests.Results: Both groups were comparable regarding demographic data. Mean arterial blood pressure (MAP) in Group O was lower than Group M at 5 to 25 minutes and difference of MAP between the two groups was > 20% of baseline values (p < 0.05). HR was comparable between groups. No statistically significant differences were seen in side effects between the two groups.Conclusion: Our study shows that the preemptive use of both ondansetron and mephentermine significantly decreases the incidence of post-spinal hypotension.
背景和目的:脊髓麻醉是一种常伴有低血压和心动过缓等副作用的技术。最近的研究表明,使用昂丹司琼可降低由脊髓麻醉引起的低血压的发生率。这项前瞻性、随机、对照、双盲研究的目的是比较预防性静脉注射昂丹司琼和甲芬特明治疗脊柱后低血压的疗效。方法:将130例患者随机分为两组:O组给予静脉注射昂丹司琼4 mg, M组给予静脉注射甲非明6 mg。所有患者均使用3ml 0.5%高压布比卡因进行脊髓麻醉。脊髓麻醉后30分钟测量血压和心率(HR)。定量资料采用方差分析,定性资料采用卡方检验。结果:两组人口统计数据具有可比性。5 ~ 25 min时,O组平均动脉血压(MAP)低于M组,两组间MAP差异为基线值的20% (p < 0.05)。两组间人力资源具有可比性。两组的副作用无统计学差异。结论:我们的研究表明,优先使用昂丹司琼和甲非明可显著降低脊髓后低血压的发生率。
{"title":"Comparison between mephentermine and ondansetron for the prevention of post spinal hypotension: a prospective randomized trial","authors":"K. Shah, P. Dubey, A. Bharti, S. Singh","doi":"10.56126/72.3.5","DOIUrl":"https://doi.org/10.56126/72.3.5","url":null,"abstract":"Background and Aims: Spinal anesthesia is a technique often associated with side effects like hypotension and bradycardia. Recent studies have shown that the use of ondansetron leads to a decreased incidence of hypotension induced by spinal anesthesia. This prospective, randomized, controlled, double-blind study was done to compare the efficacy of the prophylactic use of intravenous (IV) ondansetron and mephentermine on post-spinal hypotension.\u0000\u0000Methods: A total of 130 patients were randomly allocated to one of two groups: Group O received 4 mg IV ondansetron and Group M received 6 mg of IV mephentermine. All patients received spinal anesthesia using 3 mL of 0.5% hyperbaric bupivacaine. Assessment of blood pressure and heart rate (HR) was done for 30 minutes after spinal anesthesia was performed. Quantitative data were analyzed using ANOVA tests and qualitative data were analyzed using the Chi-square tests.\u0000\u0000Results: Both groups were comparable regarding demographic data. Mean arterial blood pressure (MAP) in Group O was lower than Group M at 5 to 25 minutes and difference of MAP between the two groups was > 20% of baseline values (p < 0.05). HR was comparable between groups. No statistically significant differences were seen in side effects between the two groups.\u0000\u0000Conclusion: Our study shows that the preemptive use of both ondansetron and mephentermine significantly decreases the incidence of post-spinal hypotension.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46992364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A challenge for anaesthesiologists of the future: To reduce our foot- print on this planet 未来麻醉师面临的挑战:减少我们在这个星球上的足迹
Q4 Medicine Pub Date : 2021-06-01 DOI: 10.56126/72.2.1
M. Carella, G. Hans
{"title":"A challenge for anaesthesiologists of the future: To reduce our foot- print on this planet","authors":"M. Carella, G. Hans","doi":"10.56126/72.2.1","DOIUrl":"https://doi.org/10.56126/72.2.1","url":null,"abstract":"","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43678258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral and buccal abuse of transdermal opioids : an underdetected but potentially lethal practice 经皮阿片类药物的口腔和口腔滥用:一种检测不足但可能致命的做法
Q4 Medicine Pub Date : 2021-06-01 DOI: 10.56126/72.2.2
L. Gistelinck, G. Heylens, S. Schelfout, Glenn Lemmens
Objectives : Transdermal opioid patches (TOPs) are effective and well tolerated in patients with moderate to severe chronic pain syndromes. Their specific pharmacological properties, however, make them prone to abuse. The objective of this article is to describe the practice of oral and buccal abuse of TOPs and to discuss its clinical implications.Methods : We present the case of a patient admitted to the intensive care unit after oral abuse of transdermal opioid patches. Additionally, a narrative literature review on the topic is conducted, referring to Pubmed and Embase.Results : Oral or buccal TOP abuse is the most frequent method of TOP abuse, followed by intravenous injection, inhaling, and applying multiple patches. The main reasons for TOP abuse include drug addiction, suicidal behavior and self-medication. Oral ingestion is potentially lethal because of the high doses of fentanyl that are found in a single patch. Buccal abuse results in fast elevations of fentanyl serum concentrations, caused by transmucosal absorption of fentanyl, thus bypassing hepatic metabolism. During emergency management, naloxone should be administered in a continuous infusion, given the high risk of recurrence of symptoms. Evidence suggests that transdermal buprenorphine is safer in terms of abuse potential. This is explained by its ceiling effect for respiratory depression and its lower peak effects in supratherapeutic doses. Risk factors for abuse include history of substance use disorder, prior opioid overdose and mental illness. Patients with suspected opioid abuse should be referred to pain clinics, mental health specialists or drug addiction facilities.Conclusion : Oral or buccal abuse is the most reported non-dermal form of TOP abuse. When ingested or chewed, TOPs pose considerable health risks. It is critical to screen patients with chronic opioid therapy regularly for opioid use disorder. When confronted with patients at risk of abuse, close monitoring and referral to specialist care is advised.
目的:经皮阿片贴片(TOPs)对中重度慢性疼痛综合征患者有效且耐受性良好。然而,它们特殊的药理特性使它们容易被滥用。本文的目的是描述口腔和口腔滥用TOPs的实践,并讨论其临床意义。方法:我们介绍一例患者在口服阿片类透皮贴剂后进入重症监护室。此外,还参考Pubmed和Embase对该主题进行了叙述性文献综述。结果:口腔或口腔滥用TOP是滥用TOP最常见的方法,其次是静脉注射、吸入和应用多种贴片。TOP滥用的主要原因包括吸毒、自杀行为和自我药物治疗。口服可能是致命的,因为在单个贴片中发现了高剂量的芬太尼。口腔滥用导致芬太尼血清浓度快速升高,这是由芬太尼的跨粘膜吸收引起的,从而绕过肝脏代谢。在紧急情况下,考虑到症状复发的高风险,纳洛酮应连续输注。有证据表明,就滥用潜力而言,经皮丁丙诺啡更安全。这可以通过其对呼吸抑制的上限效应和超治疗剂量的低峰值效应来解释。滥用的风险因素包括药物使用障碍史、既往阿片类药物过量和精神疾病。疑似阿片类药物滥用的患者应转诊至疼痛诊所、心理健康专家或戒毒机构。结论:口腔或口腔虐待是最常见的非皮肤形式的TOP虐待。摄入或咀嚼时,TOPs会对健康造成相当大的风险。定期筛查慢性阿片类药物治疗患者的阿片类物质使用障碍至关重要。当遇到有虐待风险的患者时,建议密切监测并转诊至专科护理。
{"title":"Oral and buccal abuse of transdermal opioids : an underdetected but potentially lethal practice","authors":"L. Gistelinck, G. Heylens, S. Schelfout, Glenn Lemmens","doi":"10.56126/72.2.2","DOIUrl":"https://doi.org/10.56126/72.2.2","url":null,"abstract":"Objectives : Transdermal opioid patches (TOPs) are effective and well tolerated in patients with moderate to severe chronic pain syndromes. Their specific pharmacological properties, however, make them prone to abuse. The objective of this article is to describe the practice of oral and buccal abuse of TOPs and to discuss its clinical implications.\u0000\u0000Methods : We present the case of a patient admitted to the intensive care unit after oral abuse of transdermal opioid patches. Additionally, a narrative literature review on the topic is conducted, referring to Pubmed and Embase.\u0000\u0000Results : Oral or buccal TOP abuse is the most frequent method of TOP abuse, followed by intravenous injection, inhaling, and applying multiple patches. The main reasons for TOP abuse include drug addiction, suicidal behavior and self-medication. Oral ingestion is potentially lethal because of the high doses of fentanyl that are found in a single patch. Buccal abuse results in fast elevations of fentanyl serum concentrations, caused by transmucosal absorption of fentanyl, thus bypassing hepatic metabolism. During emergency management, naloxone should be administered in a continuous infusion, given the high risk of recurrence of symptoms. Evidence suggests that transdermal buprenorphine is safer in terms of abuse potential. This is explained by its ceiling effect for respiratory depression and its lower peak effects in supratherapeutic doses. Risk factors for abuse include history of substance use disorder, prior opioid overdose and mental illness. Patients with suspected opioid abuse should be referred to pain clinics, mental health specialists or drug addiction facilities.\u0000\u0000Conclusion : Oral or buccal abuse is the most reported non-dermal form of TOP abuse. When ingested or chewed, TOPs pose considerable health risks. It is critical to screen patients with chronic opioid therapy regularly for opioid use disorder. When confronted with patients at risk of abuse, close monitoring and referral to specialist care is advised.","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46243677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intraoperative management and hemodynamic monitoring for ma- jor abdominal surgery : a narrative review 大腹部手术的术中管理和血流动力学监测:叙述性回顾
Q4 Medicine Pub Date : 2021-06-01 DOI: 10.56126/72.2.3
A. Russo, B. Romano
Background : Several trials suggest that postoperative outcomes may be improved by the use of hemodynamic monitoring, but a survey by the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology (ESA) showed that cardiac output is monitored by only 34% of ASA and ESA respondents and central venous pressure is monitored by 73% of ASA respondents and 84% of ESA respondents.Moreover, 86.5% of ASA respondents and 98.1% of ESA respondents believe that their current hemodynamic management could be improved (1). The interaction of general anesthesia and surgical stress is the main problem and the leading cause for postoperative morbidity and mortality. The choice of a suitable hemodynamic monitoring system for patients at high anesthesiological risk is of crucial importance to reduce the incidence of major postoperative complications. The aim of the present review is to summarize the benefits of a defined path beginning before surgery, and discuss the available evidence supporting the efficacy and safety of an individualized hemodynamic approach for major abdominal surgery.Objective : To evaluate the clinical effectiveness of a perioperative hemodynamic therapy algorithm in high risk patients
背景:一些试验表明,使用血液动力学监测可以改善术后结果,但美国麻醉师学会(ASA)和欧洲麻醉学学会(ESA)的一项调查显示,只有34%的ASA和ESA受访者监测心输出量,73%的ASA和84%的ESA受访者监测中心静脉压。此外,86.5%的ASA受访者和98.1%的ESA受访者认为他们目前的血液动力学管理可以改善(1)。全身麻醉和手术压力的相互作用是术后发病率和死亡率的主要问题和主要原因。为高麻醉风险患者选择合适的血液动力学监测系统对于降低术后主要并发症的发生率至关重要。本综述的目的是总结手术前开始的明确路径的益处,并讨论支持个体化血液动力学方法在腹部大手术中的有效性和安全性的现有证据。目的:评估高危患者围手术期血液动力学治疗算法的临床有效性
{"title":"Intraoperative management and hemodynamic monitoring for ma- jor abdominal surgery : a narrative review","authors":"A. Russo, B. Romano","doi":"10.56126/72.2.3","DOIUrl":"https://doi.org/10.56126/72.2.3","url":null,"abstract":"Background : Several trials suggest that postoperative outcomes may be improved by the use of hemodynamic monitoring, but a survey by the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology (ESA) showed that cardiac output is monitored by only 34% of ASA and ESA respondents and central venous pressure is monitored by 73% of ASA respondents and 84% of ESA respondents.\u0000Moreover, 86.5% of ASA respondents and 98.1% of ESA respondents believe that their current hemodynamic management could be improved (1). The interaction of general anesthesia and surgical stress is the main problem and the leading cause for postoperative morbidity and mortality. The choice of a suitable hemodynamic monitoring system for patients at high anesthesiological risk is of crucial importance to reduce the incidence of major postoperative complications. The aim of the present review is to summarize the benefits of a defined path beginning before surgery, and discuss the available evidence supporting the efficacy and safety of an individualized hemodynamic approach for major abdominal surgery.\u0000\u0000Objective : To evaluate the clinical effectiveness of a perioperative hemodynamic therapy algorithm in high risk patients","PeriodicalId":7024,"journal":{"name":"Acta anaesthesiologica Belgica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45210587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta anaesthesiologica Belgica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1